Lentiviruses inefficiently incorporate human parainfluenza type 3 envelope proteins
1The Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University, Atlanta, Georgia 30332-0535, USA.
Abstract:
We have previously shown that the envelope glycoproteins of human parainfluenza type 3 (HPIV3), F and HN, are able to pseudotype lentiviruses, but the titers of these viruses are too low for use in clinical gene transfer. In this study we investigated the cause of these low titers. We compared the mRNA and protein expression levels of HN and F in transfected cells and in cells infected with wild-type HPIV3. Transfected cells contained similar levels of HN and F cytosolic mRNA, but fewer cell-surface HN and F proteins (3.8- and 1.3-fold less, respectively), than cells infected with wild-type HPIV3. To increase expression of HN in transfected cells, we codon-optimized HN and used it to transfect lentivirus producer cells. Cell surface expression of HN, as well as the amount of HN incorporated into virus particles, increased two- to threefold. Virus titers increased 1.2- to 6.4-fold, and the transduction efficiency of polarized MDCK cells via their apical surfaces increased 1.4-fold. Interestingly, even though codon optimization improved the expression levels of HN and virus titers, we found that HPIV3 pseudotyped viruses contained about 14-fold fewer envelope proteins than lentiviruses pseudotyped with the amphotropic envelope protein. Taken together, our findings suggest that titers are low, not because virus producer cells express levels of HPIV3 envelope proteins that are too low, but because too few of these proteins are incorporated by the lentiviruses for them to be able to efficiently transduce cells.
Insights
Low titers of human parainfluenza virus type 3 (HPIV3) lentiviral vectors are not due to insufficient envelope protein expression. Instead, limited incorporation of these HPIV3 proteins into lentiviruses hinders efficient cell transduction.
Area of Science:
- Virology
- Gene Therapy
- Molecular Biology
Background:
- Human parainfluenza virus type 3 (HPIV3) envelope glycoproteins (F and HN) can pseudotype lentiviruses.
- Current HPIV3-pseudotyped lentiviruses exhibit low titers, limiting their clinical gene transfer applications.
Purpose of the Study:
- Investigate the reasons behind low titers of HPIV3-pseudotyped lentiviruses.
- Determine strategies to enhance the efficiency of HPIV3-based lentiviral vectors for gene therapy.
Main Methods:
- Compared mRNA and protein expression of HPIV3 F and HN glycoproteins in transfected cells versus wild-type HPIV3-infected cells.
- Utilized codon optimization of the HN gene to enhance its expression in lentivirus producer cells.
- Quantified cell-surface protein levels, viral incorporation, virus titers, and transduction efficiency.
Main Results:
- Transfected cells showed similar mRNA levels but lower cell-surface F and HN protein expression compared to infected cells.
- Codon optimization of HN increased cell-surface expression, viral incorporation, and virus titers (1.2- to 6.4-fold).
- HPIV3 pseudotyped lentiviruses incorporated significantly fewer envelope proteins than amphotropic lentiviruses.
Conclusions:
- Low titers of HPIV3-pseudotyped lentiviruses are primarily due to inefficient incorporation of envelope glycoproteins into the viral particles, not low expression in producer cells.
- Codon optimization can improve HPIV3 envelope protein expression and vector titers.
- Further optimization is needed to increase envelope protein incorporation for enhanced gene transfer efficiency.
Related Concept Videos
Inhibitors Of Virion Release
Inhibitors of Virion Maturation and Assembly
Leaky Scanning
Retroviruses
Influenza
Inhibitors of Viral Protein Synthesis


